Scalp Cooling in MBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Chemotherapy-induced Alopecia
Interventions: DEVICE: Paxman Scalp Cooling System|DRUG: Eribulin|DRUG: Sacituzumab govitecan|DRUG: Trastuzumab deruxtecan
Sponsor: Dana-Farber Cancer Institute
Collaborators: Paxman Coolers Limited|AstraZeneca|Eisai Inc.|Daiichi Sankyo|Gilead Sciences